120 related articles for article (PubMed ID: 17290078)
1. Combined hepatocholangiocarcinoma: case-series and review of literature.
Bhagat V; Javle M; Yu J; Agrawal A; Gibbs JF; Kuvshinoff B; Nava E; Iyer R
Int J Gastrointest Cancer; 2006; 37(1):27-34. PubMed ID: 17290078
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
3. Hepatic resection for combined hepatocellular and cholangiocarcinoma.
Liu CL; Fan ST; Lo CM; Ng IO; Lam CM; Poon RT; Wong J
Arch Surg; 2003 Jan; 138(1):86-90. PubMed ID: 12511158
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
[TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
7. Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma.
Zhou YM; Sui CJ; Zhang XF; Li B; Yang JM
BMC Gastroenterol; 2017 Feb; 17(1):25. PubMed ID: 28183290
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous rupture of hepatocellular carcinoma: a Western experience.
Battula N; Madanur M; Priest O; Srinivasan P; O'Grady J; Heneghan MA; Bowles M; Muiesan P; Heaton N; Rela M
Am J Surg; 2009 Feb; 197(2):164-7. PubMed ID: 18926518
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
14. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series.
Wu ZF; Zhang HB; Yang N; Zhao WC; Fu Y; Yang GS
Eur J Surg Oncol; 2012 Jul; 38(7):602-10. PubMed ID: 22417704
[TBL] [Abstract][Full Text] [Related]
16. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
[TBL] [Abstract][Full Text] [Related]
17. Minute mixed hepatoma with two components: hepatocellular and cholangiocarcinoma, which developed on liver cirrhosis with HCV.
Tanaka T; Imamura A; Hayashi S; Tsuruta K; Igari T; Koike M; Tanaka S
Hepatogastroenterology; 1998; 45(19):220-3. PubMed ID: 9496517
[TBL] [Abstract][Full Text] [Related]
18. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
Zhou YM; Yang JM; Wang B; Xu F; Tong Y; Li DQ
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):656-9. PubMed ID: 18086637
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
[TBL] [Abstract][Full Text] [Related]
20. Malignancy associated with hepatolithiasis.
Chu KM; Lo CM; Liu CL; Fan ST
Hepatogastroenterology; 1997; 44(14):352-7. PubMed ID: 9164501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
